Requirements and Registration for Healthcare Associated Venous Thromboembolism Prevention Challenge; Amendment of Notice, 38185 [2016-13850]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–13847 Filed 6–10–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
organizations. Champions were
recognized as HA–VTE Prevention
Champions and will receive a cash
award of $10,000. A maximum of
$80,000 will now be awarded in this
challenge, an increase of $10,000.
Additional honorable mention awards
were also made to deserving entries.
Federal and international winners
received non-monetary recognition but
no prize.
Authority: 15 U.S.C. 3719.
Centers for Disease Control and
Prevention (CDC)
Dated: June 7, 2016.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
Requirements and Registration for
Healthcare Associated Venous
Thromboembolism Prevention
Challenge; Amendment of Notice
[FR Doc. 2016–13850 Filed 6–10–16; 8:45 am]
BILLING CODE 4163–18–P
Authority: 15 U.S.C. 3719.
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AWARD APPROVING OFFICIAL: Thomas R.
Frieden, MD, MPH, Director, Centers for
Disease Control and Prevention, and
Administrator, Agency for Toxic
Substances and Disease Registry.
ACTION: Notice.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The Centers for Disease
Control and Prevention (CDC) located
within the Department of Health and
Human Services (HHS) announces an
amendment to its notice entitled,
Announcement of Requirements and
Registration for Healthcare Associated
Venous Thromboembolism Prevention
Challenge. This amendment is being
made to reflect an increase in the
number of Champions and change the
maximum total prize disbursement.
There are no other changes to the
September 22, 2015 notice.
FOR FURTHER INFORMATION CONTACT:
Michele Beckman, Division of Blood
Disorders, National Center on Birth
Defects and Developmental Disabilities,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE.,
Mailstop E–64, Atlanta, GA 30329,
Telephone: 404–498–6474, Fax: 404–
498–6799, Attention: HA–VTE
Prevention Challenge, Email:
havtechallenge@cdc.gov.
SUPPLEMENTARY INFORMATION:
Subject of Challenge Competition: On
September 22, 2015 CDC announced the
Requirements and Registration for
Healthcare Associated Venous
Thromboembolism Prevention
Challenge (80 FR 57187). This notice
announces an increase in the number of
Champions, from 7 to 8. The Champions
were selected from the highest scoring
U.S. hospitals, multi-hospital systems,
hospital networks, and managed care
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
AGENCY:
srobinson on DSK5SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:48 Jun 10, 2016
Jkt 238001
Centers for Disease Control and
Prevention
[30-Day–16–16CA]
Agency Forms Undergoing Paperwork
Reduction Act Review
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
38185
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Update seat belt fit recommendation
for children—New—National Center for
Injury Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) is seeking OMB
approval to conduct a new information
collection for a study entitled, ‘‘Update
Seat Belt Fit Recommendation for
Children,’’ over a period of three years.
CDC seeks to measure how seat belts
fit children in vehicles with and
without booster seats. The scientific
basis for the current height
recommendation for when children can
transition from using a booster seat to
just a seat belt is from a 1993 study that
is outdated (Durbin et al., 2011; Reed et
al., 2013). The goal of the new collection
is to use the latest technology among the
largest sample of children to date to
help inform when children can safely
transition from using a booster seat with
a seat belt to using only a seat belt.
Findings from this data collection will
inform CDC’s child passenger safety
recommendation regarding when
children can safely transition from using
a booster seat with the seat belt to using
only the seat belt. This study will also
provide information on ways to further
reduce motor vehicle-related injuries
and deaths among children.
Prospective study participants will be
children aged 6–12 years old in the
greater District of Columbia (DC) area.
Parents of prospective study
participants will answer a series of
screening questions to determine
eligibility. Children who meet the
screening criteria and are willing to
participate will complete an in-person
measurement session. Data will be
analyzed using descriptive statistics,
mean, standard deviation, and logistic
regression. Selected findings will
eventually be published in a peerreviewed journal.
The estimated annual burden hours
are 466. There are no costs to
respondents other than their time.
E:\FR\FM\13JNN1.SGM
13JNN1
]]>Agencies
[Federal Register Volume 81, Number 113 (Monday, June 13, 2016)]
[Notices]
[Page 38185]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13850]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Requirements and Registration for Healthcare Associated Venous
Thromboembolism Prevention Challenge; Amendment of Notice
Authority: 15 U.S.C. 3719.
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
AWARD APPROVING OFFICIAL: Thomas R. Frieden, MD, MPH, Director,
Centers for Disease Control and Prevention, and Administrator, Agency
for Toxic Substances and Disease Registry.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) located
within the Department of Health and Human Services (HHS) announces an
amendment to its notice entitled, Announcement of Requirements and
Registration for Healthcare Associated Venous Thromboembolism
Prevention Challenge. This amendment is being made to reflect an
increase in the number of Champions and change the maximum total prize
disbursement. There are no other changes to the September 22, 2015
notice.
FOR FURTHER INFORMATION CONTACT: Michele Beckman, Division of Blood
Disorders, National Center on Birth Defects and Developmental
Disabilities, Centers for Disease Control and Prevention, 1600 Clifton
Road NE., Mailstop E-64, Atlanta, GA 30329, Telephone: 404-498-6474,
Fax: 404-498-6799, Attention: HA-VTE Prevention Challenge, Email:
havtechallenge@cdc.gov.
SUPPLEMENTARY INFORMATION:
Subject of Challenge Competition: On September 22, 2015 CDC
announced the Requirements and Registration for Healthcare Associated
Venous Thromboembolism Prevention Challenge (80 FR 57187). This notice
announces an increase in the number of Champions, from 7 to 8. The
Champions were selected from the highest scoring U.S. hospitals, multi-
hospital systems, hospital networks, and managed care organizations.
Champions were recognized as HA-VTE Prevention Champions and will
receive a cash award of $10,000. A maximum of $80,000 will now be
awarded in this challenge, an increase of $10,000. Additional honorable
mention awards were also made to deserving entries. Federal and
international winners received non-monetary recognition but no prize.
Authority: 15 U.S.C. 3719.
Dated: June 7, 2016.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2016-13850 Filed 6-10-16; 8:45 am]
BILLING CODE 4163-18-P
